XML 19 R6.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Statements of Changes in Stockholders’ Equity - USD ($)
Total
Cumulative Effect, Period of Adoption, Adjustment
Preferred Stock
Series A
Preferred Stock
Series C
Preferred Stock
Series C
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Additional Paid in Capital
Additional Paid in Capital
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Deficit
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
Beginning balance (in shares) at Dec. 31, 2019     85,581 1,827   3,760,255        
Beginning balance at Dec. 31, 2019 $ 15,616,697   $ 855,808 $ 861,033   $ 375 $ 97,651,006   $ (83,751,525)  
Changes in Stockholders' Equity                    
Net loss (20,353,938)               (20,353,938)  
Stock-based compensation expense 2,379,360           2,379,360      
Conversion of preferred stock to common (in shares)       (10)   92        
Conversion of preferred stock to common 0     $ (10,000)     10,000      
Accretion of discount 0     $ 5,287     (5,287)      
Issuance of common stock, net (in shares)           28,262,806        
Issuance of common stock, net 42,866,272         $ 2,828 42,863,444      
Warrant exercises (in shares)           2,000        
Warrant exercises 12,000           12,000      
Ending balance (in shares) at Dec. 31, 2020     85,581 1,817   32,025,153        
Ending balance at Dec. 31, 2020 $ 40,520,391 $ 11,673 $ 855,808 $ 856,320 $ 5,816 $ 3,203 142,910,523 $ (3,314,663) (104,105,463) $ 3,326,336
Changes in Stockholders' Equity                    
Accounting Standards Update [Extensible Enumeration] Accounting Standards Update 2020-06 [Member]                  
Net loss $ (6,063,517)                  
Ending balance at Mar. 31, 2021 117,580,017     $ 846,320     222,712,911   (106,842,645)  
Beginning balance (in shares) at Dec. 31, 2020     85,581 1,817   32,025,153        
Beginning balance at Dec. 31, 2020 40,520,391 $ 11,673 $ 855,808 $ 856,320 $ 5,816 $ 3,203 142,910,523 $ (3,314,663) (104,105,463) $ 3,326,336
Changes in Stockholders' Equity                    
Net loss (32,722,168)               (32,722,168)  
Stock-based compensation expense 3,031,507           3,031,507      
Conversion of preferred stock to common (in shares)       (11)   101        
Conversion of preferred stock to common 0     $ (11,000)     11,000      
Issuance of common stock, net (in shares)           44,200,000        
Issuance of common stock, net 82,153,600         $ 4,420 82,149,180      
Ending balance (in shares) at Dec. 31, 2021     85,581 1,806   76,225,254        
Ending balance at Dec. 31, 2021 92,995,003   $ 855,808 $ 845,320   $ 7,623 224,787,547   (133,501,295)  
Beginning balance at Mar. 31, 2021 117,580,017     846,320     222,712,911   (106,842,645)  
Changes in Stockholders' Equity                    
Net loss (7,667,105)                  
Ending balance at Jun. 30, 2021 110,724,864     846,320     223,524,863   (114,509,750)  
Changes in Stockholders' Equity                    
Net loss (9,269,473)                  
Ending balance at Sep. 30, 2021 $ 102,643,766     $ 845,320     $ 224,714,238   $ (123,779,223)